Stay updated on ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC

Sign up to get notified when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.
Latest website image capture
Clouds background image

Latest updates to the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision identifier advances from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T16:15:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T16:12:19.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating restricted access to the record. The visible page chrome and footer remain, but the study information cannot be loaded.
    Difference
    19%
    Check dated 2026-09-20T19:45:22.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor administrative update to the study details page without altering the trial information.
    Difference
    0.0%
    Check dated 2026-08-30T16:05:28.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.5, replacing the previous v3.6.4. This indicates a small update to the page's metadata, without changing substantive content.
    Difference
    0.0%
    Check dated 2026-08-08T23:50:57.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a newer page revision. This update does not modify study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-07-25T16:46:16.000Z thumbnail image

Stay in the know with updates to ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC

Enter your email address, and we'll notify you when there's something new on the ENHANCE-1 Clinical Trial: Eribulin + Pembrolizumab in mTNBC page.